189 related articles for article (PubMed ID: 8552413)
1. Specific IgG1 and IgG2 antibody responses of dogs to Leishmania infantum and other parasites.
Deplazes P; Smith NC; Arnold P; Lutz H; Eckert J
Parasite Immunol; 1995 Sep; 17(9):451-8. PubMed ID: 8552413
[TBL] [Abstract][Full Text] [Related]
2. Leishmania infantum-specific IgG, IgG1 and IgG2 antibody responses in healthy and ill dogs from endemic areas. Evolution in the course of infection and after treatment.
Solano-Gallego L; Riera C; Roura X; Iniesta L; Gallego M; Valladares JE; Fisa R; Castillejo S; Alberola J; Ferrer L; Arboix M; Portús M
Vet Parasitol; 2001 Apr; 96(4):265-76. PubMed ID: 11267753
[TBL] [Abstract][Full Text] [Related]
3. Specific IgG1 and IgG2 antibody and lymphocyte subset levels in naturally Leishmania infantum-infected treated and untreated dogs.
Bourdoiseau G; Bonnefont C; Hoareau E; Boehringer C; Stolle T; Chabanne L
Vet Immunol Immunopathol; 1997 Oct; 59(1-2):21-30. PubMed ID: 9437823
[TBL] [Abstract][Full Text] [Related]
4. Cell mediated immunity and specific IgG1 and IgG2 antibody response in natural and experimental canine leishmaniosis.
Leandro C; Santos-Gomes GM; Campino L; Romão P; Cortes S; Rolão N; Gomes-Pereira S; Riça Capela MJ; Abranches P
Vet Immunol Immunopathol; 2001 May; 79(3-4):273-84. PubMed ID: 11389961
[TBL] [Abstract][Full Text] [Related]
5. Comparative analysis of the Leishmania infantum-specific antibody repertoires and the autoantibody repertoires between asymptomatic and symptomatic dogs.
Chaabouni A; Boubaker Elandoulsi R; Mhadhbi M; Gharbi M; Sassi A
Vet Parasitol; 2018 Sep; 261():9-17. PubMed ID: 30253856
[TBL] [Abstract][Full Text] [Related]
6. Idiotype expression of IgG1 and IgG2 in dogs naturally infected with Leishmania infantum.
Iniesta L; Gállego M; Portús M
Vet Immunol Immunopathol; 2007 Oct; 119(3-4):189-97. PubMed ID: 17631971
[TBL] [Abstract][Full Text] [Related]
7. Identification of antibodies to Leishmania silent information regulatory 2 (SIR2) protein homologue during canine natural infections: pathological implications.
Cordeiro-da-Silva A; Cardoso L; Araújo N; Castro H; Tomás A; Rodrigues M; Cabral M; Vergnes B; Sereno D; Ouaissi A
Immunol Lett; 2003 Apr; 86(2):155-62. PubMed ID: 12644317
[TBL] [Abstract][Full Text] [Related]
8. Early reduction of Leishmania infantum-specific antibodies and blood parasitemia during treatment in dogs with moderate or severe disease.
Solano-Gallego L; Di Filippo L; Ordeix L; Planellas M; Roura X; Altet L; Martínez-Orellana P; Montserrat S
Parasit Vectors; 2016 May; 9(1):235. PubMed ID: 27160317
[TBL] [Abstract][Full Text] [Related]
9. IgG subclass responses in a longitudinal study of canine visceral leishmaniasis.
Quinnell RJ; Courtenay O; Garcez LM; Kaye PM; Shaw MA; Dye C; Day MJ
Vet Immunol Immunopathol; 2003 Feb; 91(3-4):161-8. PubMed ID: 12586479
[TBL] [Abstract][Full Text] [Related]
10. Gentamicin-attenuated Leishmania infantum: cellular immunity production and protection of dogs against experimental canine leishmaniasis.
Daneshvar H; Molaei MM; Kamiabi H; Burchmore R; Hagan P; Stephen Phillips R
Parasite Immunol; 2010; 32(11-12):722-30. PubMed ID: 21039612
[TBL] [Abstract][Full Text] [Related]
11. Anti-Leishmania humoral and cellular immune responses in naturally infected symptomatic and asymptomatic dogs.
Cardoso L; Schallig HD; Cordeiro-da-Silva A; Cabral M; Alunda JM; Rodrigues M
Vet Immunol Immunopathol; 2007 May; 117(1-2):35-41. PubMed ID: 17321602
[TBL] [Abstract][Full Text] [Related]
12. Comparison of monoclonal and polyclonal antibodies for the detection of canine IgG1 and IgG2, and associations with infection outcome in Leishmania infantum naturally infected dogs.
Carson C; Quinnell RJ; Day MJ; Courtenay O
Vet Immunol Immunopathol; 2010 Feb; 133(2-4):264-8. PubMed ID: 19726090
[TBL] [Abstract][Full Text] [Related]
13. Immunoglobulin G and E responses in various stages of canine leishmaniosis.
Iniesta L; Gállego M; Portús M
Vet Immunol Immunopathol; 2005 Jan; 103(1-2):77-81. PubMed ID: 15626463
[TBL] [Abstract][Full Text] [Related]
14. IgG1/IgG2 antibody dichotomy in sera of vaccinated or naturally infected dogs with visceral leishmaniosis.
de Oliveira Mendes C; Paraguai de Souza E; Borja-Cabrera GP; Maria Melo Batista L; Aparecida dos Santos M; Ellner Parra L; Menz I; Palatnik M; Palatnik de Sousa CB
Vaccine; 2003 Jun; 21(19-20):2589-97. PubMed ID: 12744895
[TBL] [Abstract][Full Text] [Related]
15. Analysis of the humoral immune response against total and recombinant antigens of Leishmania infantum: correlation with disease progression in canine experimental leishmaniasis.
Nieto CG; García-Alonso M; Requena JM; Mirón C; Soto M; Alonso C; Navarrete I
Vet Immunol Immunopathol; 1999 Feb; 67(2):117-30. PubMed ID: 10077418
[TBL] [Abstract][Full Text] [Related]
16. Serological and parasitological follow-up in dogs experimentally infected with Leishmania infantum and treated with meglumine antimoniate.
Riera C; Valladares JE; Gállego M; Aisa MJ; Castillejo S; Fisa R; Ribas N; Carrió J; Alberola J; Arboix M
Vet Parasitol; 1999 Jul; 84(1-2):33-47. PubMed ID: 10435789
[TBL] [Abstract][Full Text] [Related]
17. Antileishmanial antibody profile in dogs naturally infected with Leishmania chagasi.
Almeida MA; Jesus EE; Sousa-Atta ML; Alves LC; Berne ME; Atta AM
Vet Immunol Immunopathol; 2005 Jun; 106(1-2):151-8. PubMed ID: 15911002
[TBL] [Abstract][Full Text] [Related]
18. Leishmania infantum nucleoside triphosphate diphosphohydrolase 1 (NTPDase 1) B-domain: Antibody antiproliferative effect on the promastigotes and IgG subclass responses in canine visceral leishmaniasis.
Maia ACRG; Porcino GN; Faria-Pinto P; Mendes TV; Antinarelli LMR; Coimbra ES; Reis AB; Juliano L; Juliano MA; Marques MJ; Vasconcelos EG
Vet Parasitol; 2019 Jul; 271():38-44. PubMed ID: 31303201
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of an immunochemotherapeutic protocol constituted of N-methyl meglumine antimoniate (Glucantime) and the recombinant Leish-110f + MPL-SE vaccine to treat canine visceral leishmaniasis.
Miret J; Nascimento E; Sampaio W; França JC; Fujiwara RT; Vale A; Dias ES; Vieira E; da Costa RT; Mayrink W; Campos Neto A; Reed S
Vaccine; 2008 Mar; 26(12):1585-94. PubMed ID: 18328956
[TBL] [Abstract][Full Text] [Related]
20. Long-lasting protection against canine visceral leishmaniasis using the LiESAp-MDP vaccine in endemic areas of France: double-blind randomised efficacy field trial.
Lemesre JL; Holzmuller P; Gonçalves RB; Bourdoiseau G; Hugnet C; Cavaleyra M; Papierok G
Vaccine; 2007 May; 25(21):4223-34. PubMed ID: 17395339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
